Подписаться
Martin Selmansberger
Martin Selmansberger
Подтвержден адрес электронной почты в домене helmholtz-muenchen.de
Название
Процитировано
Процитировано
Год
CLIP2 as radiation biomarker in papillary thyroid carcinoma
M Selmansberger, A Feuchtinger, L Zurnadzhy, A Michna, JC Kaiser, ...
Oncogene 34 (30), 3917-3925, 2015
582015
Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles …
A Michna, U Schötz, M Selmansberger, H Zitzelsberger, K Lauber, ...
Radiation Oncology 11, 1-16, 2016
442016
Natural cubic spline regression modeling followed by dynamic network reconstruction for the identification of radiation-sensitivity gene association networks from time-course …
A Michna, H Braselmann, M Selmansberger, A Dietz, J Hess, M Gomolka, ...
PloS one 11 (8), e0160791, 2016
402016
Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas
M Selmansberger, JC Kaiser, J Hess, D Güthlin, I Likhtarev, V Shpak, ...
Carcinogenesis 36 (7), 748-756, 2015
372015
Expression of mi RNA‐26b‐5p and its target TRPS 1 is associated with radiation exposure in post‐C hernobyl breast cancer
CM Wilke, J Hess, SV Klymenko, VV Chumak, LM Zakhartseva, ...
International journal of cancer 142 (3), 573-583, 2018
362018
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical …
J Hess, K Unger, M Orth, U Schoetz, L Schuettrumpf, V Zangen, ...
Cancer letters 386, 87-99, 2017
322017
Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment
JC Kaiser, R Meckbach, M Eidemüller, M Selmansberger, K Unger, ...
Carcinogenesis, bgw102, 2016
322016
Comparative transcriptomic analysis of temozolomide resistant primary GBM stem-like cells and recurrent GBM identifies up-regulation of the carbonic anhydrase CA2 gene as …
R Hannen, M Selmansberger, M Hauswald, A Pagenstecher, A Nist, ...
Cancers 11 (7), 921, 2019
252019
A prognostic mRNA expression signature of four 16q24. 3 genes in radio (chemo) therapy‐treated head and neck squamous cell carcinoma (HNSCC)
L Wintergerst, M Selmansberger, C Maihoefer, L Schüttrumpf, A Walch, ...
Molecular Oncology 12 (12), 2085-2101, 2018
232018
Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian–American Cohort
M Selmansberger, H Braselmann, J Hess, T Bogdanova, M Abend, ...
Carcinogenesis 36 (11), 1381-1387, 2015
232015
Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
I Summerer, J Hess, A Pitea, K Unger, L Hieber, M Selmansberger, ...
BMC genomics 16, 1-16, 2015
152015
A genomic copy number signature predicts radiation exposure in post‐C hernobyl breast cancer
CM Wilke, H Braselmann, J Hess, SV Klymenko, VV Chumak, ...
International Journal of Cancer 143 (6), 1505-1515, 2018
122018
Transcriptomic landscape of radiation-induced murine thyroid proliferative lesions
E Stauffer, P Weber, T Heider, C Dalke, A Blutke, A Walch, G Burgstaller, ...
Endocrine-Related Cancer 28 (3), 213-224, 2021
22021
Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2
M Selmansberger, A Michna, H Braselmann, I Höfig, K Schorpp, P Weber, ...
Radiation oncology 15, 1-13, 2020
22020
OC-0488: Prognostic biomarkers and targets for personalization of radiotherapy of HNSCC: CD44v6
U Schötz, M Orth, M Selmansberger, J Schuster, B Stegen, J Hess, ...
Radiotherapy and Oncology 127, S251, 2018
12018
Molecular markers in radiation-induced thyroid cancer
H Zitzelsberger, J Heß, M Selmansberger, G Thomas, K Unger
MELODI Workshop, 28, 2012
12012
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data
LE Schnöller, D Piehlmaier, P Weber, N Brix, DF Fleischmann, AE Nieto, ...
Radiation Oncology 18 (1), 51, 2023
2023
Patient-derived HNSCC cell lines and subclones reflect inter-and intra-tumoral heterogeneity regarding various molecular and phenotypic aspects
GA Drexler, O Klymenko, P Baumeister, P Weber, T Heider, ...
STRAHLENTHERAPIE UND ONKOLOGIE 196 (SUPPL 1), S49-S50, 2020
2020
Tumor Stem Cell Factor CD44v6 influences G2 Arrest and Radiation Sensitivity in S Phase after Irradiation
M Al Bazaz, M Selmansberger, R Engenhart-Cabillic, K Lauber, ...
STRAHLENTHERAPIE UND ONKOLOGIE 195, S127-S127, 2019
2019
A 16q24. 3 4-gene mRNA signature predicts outcome in radio (chemo) therapy-treated head and neck squamous cell carcinoma
L Wintergerst, M Selmansberger, C Maihoefer, L Schuettrumpf, A Walch, ...
STRAHLENTHERAPIE UND ONKOLOGIE 195, S24-S25, 2019
2019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20